LLY

762

-0.13%↓

JNJ

175.33

-1.02%↓

ABBV

220.83

+0.35%↑

UNH

339.31

-0.35%↓

AZN

76.87

-1.06%↓

LLY

762

-0.13%↓

JNJ

175.33

-1.02%↓

ABBV

220.83

+0.35%↑

UNH

339.31

-0.35%↓

AZN

76.87

-1.06%↓

LLY

762

-0.13%↓

JNJ

175.33

-1.02%↓

ABBV

220.83

+0.35%↑

UNH

339.31

-0.35%↓

AZN

76.87

-1.06%↓

LLY

762

-0.13%↓

JNJ

175.33

-1.02%↓

ABBV

220.83

+0.35%↑

UNH

339.31

-0.35%↓

AZN

76.87

-1.06%↓

LLY

762

-0.13%↓

JNJ

175.33

-1.02%↓

ABBV

220.83

+0.35%↑

UNH

339.31

-0.35%↓

AZN

76.87

-1.06%↓

Search

Essa Pharma Inc

Отворен

0.2

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.17

Максимум

0.21

Ключови измерители

By Trading Economics

Приходи

2.4M

-4M

EPS

-0.14

Дивидентна доходност

87.56

Марж на печалбата

-4,681.422

Служители

35

EBITDA

1.4M

-5M

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

87.56%

3.07%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-76M

9.1M

Предишно отваряне

0.2

Предишно затваряне

0.2

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

Essa Pharma Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

17.09.2025 г., 23:01 ч. UTC

Придобивния, сливания и поглъщания

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid -- Update

17.09.2025 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid

17.09.2025 г., 21:59 ч. UTC

Печалби

Cryptocurrency-Exchange Bullish Swings to Profit in First Report as Public Company

17.09.2025 г., 23:44 ч. UTC

Пазарно говорене

Nikkei May Rise as Yen Weakens -- Market Talk

17.09.2025 г., 23:39 ч. UTC

Пазарно говорене

Gold Rises Amid Prospects of Further Fed Rate Cuts -- Market Talk

17.09.2025 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Santos: XRG Consortium Wouldn't Agree to Appropriate Risk Allocation Between It and Santos Shareholders

17.09.2025 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Santos: XRG Consortium Wouldn't Agree to Acceptable Terms That Protected Value of Transaction

17.09.2025 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Santos Had Expressed Concern to XRG Consortium About Delays in Agreeing to Scheme Implementation Agreement

17.09.2025 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Santos: Consortium Notified Board of Decision to Withdraw Proposal on Weds Evening

17.09.2025 г., 22:18 ч. UTC

Придобивния, сливания и поглъщания

Santos Confirms XRG Consortium Has Withdrawn Takeover Proposal

17.09.2025 г., 21:00 ч. UTC

Печалби

Darden Restaurants to Report Earnings. Why the Olive Garden Parent Is Expected to Stay Strong. -- Barrons.com

17.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

17.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.09.2025 г., 19:59 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.09.2025 г., 19:59 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Rise as Fed Cuts, Powell Warns of Risks -- Market Talk

17.09.2025 г., 19:07 ч. UTC

Пазарно говорене

Oil Futures Snap Three-Session Winning Streak -- Market Talk

17.09.2025 г., 18:43 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Reverse Course as Powell Talks to Reporters -- Market Talk

17.09.2025 г., 18:38 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Mixed Ahead of Storage Data -- Market Talk

17.09.2025 г., 18:20 ч. UTC

Пазарно говорене

Gold Dips After Quarter-Point Rate Cut -- Market Talk

17.09.2025 г., 18:18 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.09.2025 г., 18:18 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Fall on Nearly Unanimous Fed Cut -- Market Talk

17.09.2025 г., 18:14 ч. UTC

Пазарно говорене

Oil Slips Some More as Fed Makes Expected 25 Bp Rate Cut -- Market Talk

17.09.2025 г., 17:59 ч. UTC

Пазарно говорене

Soyoil Takes Hit as Traders Consider EPA Proposal -- Market Talk

17.09.2025 г., 17:15 ч. UTC

Придобивния, сливания и поглъщания

Netflix 'Has Won The Streaming Wars,' Analyst Says. The Stock Is a Buy. -- Barrons.com

17.09.2025 г., 17:06 ч. UTC

Придобивния, сливания и поглъщания

Walmart Stock Heads for a Record High. The Retailer Could Become a Leader in 'Agentic' AI. -- Barrons.com

17.09.2025 г., 16:51 ч. UTC

Печалби

Correct: Exor 1H Net Loss -EUR624M

17.09.2025 г., 16:34 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.09.2025 г., 16:34 ч. UTC

Пазарно говорене

Bank of Canada Ditches Resilience Talk, Plays Up Slowing Growth -- Market Talk

17.09.2025 г., 16:25 ч. UTC

Печалби

Wolters Kluwer: July, August Saw a Slight Increase in Organic Growth Compared to 1H

17.09.2025 г., 16:23 ч. UTC

Печалби

Wolters Kluwer: Year-to-Date Performance In Line With 2025 Guidance

Сравнение с други в отрасъла

Ценова промяна

Essa Pharma Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

0

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

1.7 / 1.72Подкрепа & съпротива

Краткосрочен план

Bearish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
help-icon Live chat